Not a good buy right now: price is in a strong downtrend and just sold off sharply (-21.85% today), which outweighs the “oversold” signal.
Momentum is still deteriorating (negative/expanding MACD histogram), so the stock can stay oversold and keep falling.
No Intellectia buy signals today (AI Stock Picker and SwingMax both show no signal), removing the main “high-conviction” reason to buy immediately.
Financial trend is weak (revenue down YoY; still deeply loss-making), and with earnings coming (2026-02-19), near-term risk remains skewed to downside rather than a clean rebound.
Technical Analysis
Trend: Bearish structure with moving averages stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating persistent downside trend across long/medium/short timeframes.
Momentum: MACD histogram -0.012 and negatively expanding → selling pressure is strengthening, not fading.
RSI: RSI_6 = 18.07 (oversold). This can support a short-term bounce, but oversold alone is not a buy signal in a strong downtrend.
Key levels:
Pivot: 2.041 (far above current price, showing how extended the breakdown is)
Support: S1 1.405 (already below this level), next S2 1.012 (next major downside area)
Resistance: R1 2.677 / R2 3.07 (not near-term relevant unless a major reversal occurs)
Pattern-based odds (provided): mild statistical bounce potential (next day +2.59%, next week +2.66%), but next month expectation roughly flat (-0.12%), which does not counter the broader bearish trend.
can trigger a technical rebound, especially if broader market stabilizes.
Neutral/Negative Catalysts
Micro-cap profile (market cap ~ $2.60M) typically means higher dilution/financing risk and unstable price action.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: $1,598,627, down -16.66% YoY (top-line contraction).
Net income: -$4,507,260 (still a large loss), improved vs YoY by 173.19% (improvement, but remains meaningfully negative).
EPS: -9.72, down -90.18% YoY (EPS deterioration despite net income improvement—suggests per-share impact unfavorable).
Gross margin: 52.02%, slightly down (-0.23% YoY), indicating no meaningful margin expansion tailwind.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price-target change data was provided in the dataset, so a Wall Street consensus view cannot be confirmed here.
Practical read-through from available data: absent supportive analyst/target upgrades, the burden of proof remains on the stock to reverse technically and improve fundamentals.
Wall Street analysts forecast NVVE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVVE is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast NVVE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVVE is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
